- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/02 - Preparation by ring-closure or hydrogenation
Patent holdings for IPC class C07D 211/02
Total number of patents in this class: 86
10-year publication summary
|
8
|
4
|
5
|
9
|
4
|
2
|
3
|
2
|
4
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21098 |
5 |
| Florida State University Research Foundation, Inc. | 784 |
4 |
| Janssen Pharmaceutica N.V. | 3358 |
3 |
| Tesaro, Inc. | 105 |
3 |
| Northwestern University | 3457 |
2 |
| MyCell Technologies, LLC | 6 |
2 |
| Nanyang Technological University | 2075 |
2 |
| Unichem Laboratories Limited | 103 |
2 |
| Universite Claude Bernard Lyon 1 | 1041 |
2 |
| Xinfa Pharmaceutical Co., Ltd. | 22 |
2 |
| Theravance Biopharma R&D IP, LLC | 453 |
2 |
| Humanwell Pharmaceutical US | 8 |
2 |
| Merck Sharp & Dohme LLC | 3732 |
2 |
| Specialty Operations France | 868 |
2 |
| L'OREAL, Société Anonyme | 15887 |
1 |
| Merck Sharp & Dohme Corp. | 2189 |
1 |
| Massachusetts Institute of Technology | 10150 |
1 |
| Sumitomo Chemical Company, Limited | 9109 |
1 |
| Takeda Pharmaceutical Company Limited | 2721 |
1 |
| Alembic Limited | 53 |
1 |
| Other owners | 45 |